X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2970) 2970
Book Review (725) 725
Publication (131) 131
Book / eBook (24) 24
Book Chapter (19) 19
Conference Proceeding (6) 6
Newspaper Article (2) 2
Dissertation (1) 1
Journal / eJournal (1) 1
Magazine Article (1) 1
Newsletter (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2541) 2541
humans (2373) 2373
oncology (1414) 1414
male (1394) 1394
female (1345) 1345
administration, oral (1141) 1141
middle aged (1038) 1038
chemotherapy (997) 997
aged (971) 971
adult (863) 863
cancer (741) 741
etoposide - administration & dosage (735) 735
antineoplastic combined chemotherapy protocols - therapeutic use (644) 644
pharmacology & pharmacy (585) 585
treatment outcome (472) 472
etoposide (452) 452
oral etoposide (448) 448
drug administration schedule (419) 419
animals (398) 398
lung neoplasms - drug therapy (353) 353
antineoplastic combined chemotherapy protocols - adverse effects (318) 318
cisplatin (314) 314
medicine & public health (294) 294
aged, 80 and over (290) 290
therapy (282) 282
care and treatment (274) 274
etoposide - adverse effects (271) 271
adolescent (267) 267
pharmacokinetics (267) 267
neoplasms - drug therapy (261) 261
phase-ii trial (261) 261
carcinoma (257) 257
hematology (246) 246
dentistry (239) 239
trial (232) 232
phase-ii (231) 231
dentistry, oral surgery & medicine (225) 225
antineoplastic combined chemotherapy protocols - administration & dosage (224) 224
antineoplastic agents - administration & dosage (223) 223
etoposide - therapeutic use (223) 223
antineoplastic agents - therapeutic use (221) 221
cell lung-cancer (214) 214
antineoplastic agents, phytogenic - administration & dosage (213) 213
analysis (207) 207
research (206) 206
dose-response relationship, drug (204) 204
child (202) 202
antineoplastic agents - adverse effects (197) 197
cisplatin - administration & dosage (194) 194
health aspects (190) 190
infusions, intravenous (187) 187
carcinoma, small cell - drug therapy (186) 186
survival analysis (186) 186
survival rate (183) 183
prognosis (174) 174
tumors (174) 174
pharmacology/toxicology (173) 173
paclitaxel (172) 172
bioavailability (170) 170
drug therapy (170) 170
abridged index medicus (166) 166
retrospective studies (161) 161
surgery (158) 158
biological availability (154) 154
radiotherapy (154) 154
neoplasm staging (153) 153
transplantation (151) 151
combined modality therapy (150) 150
toxicity (149) 149
apoptosis (147) 147
cyclophosphamide (144) 144
child, preschool (142) 142
children (140) 140
carboplatin (138) 138
follow-up studies (137) 137
disease-free survival (136) 136
randomized trial (136) 136
carcinoma, non-small-cell lung - drug therapy (133) 133
in-vitro (132) 132
oral mucositis (132) 132
lung neoplasms - pathology (128) 128
p-glycoprotein (127) 127
prostatic neoplasms - drug therapy (127) 127
risk factors (127) 127
time factors (127) 127
neoplasm recurrence, local - drug therapy (126) 126
antineoplastic agents (124) 124
mice (124) 124
cyclophosphamide - administration & dosage (121) 121
clinical trials (120) 120
remission induction (120) 120
survival (120) 120
clinical trials as topic (119) 119
dosage and administration (118) 118
etoposide - pharmacokinetics (118) 118
ovarian neoplasms - drug therapy (118) 118
rats (118) 118
carboplatin - administration & dosage (115) 115
drug resistance, neoplasm (113) 113
cell line, tumor (111) 111
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (9) 9
Dentistry (Harry R Abbott) - Stacks (8) 8
Gerstein Science - Stacks (8) 8
Dentistry (Harry R Abbott) - Withdrawn (2) 2
Dentistry (Harry R Abbott) - Circulation Desk (1) 1
Dentistry (Harry R Abbott) - May be requested (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Theses (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Media Commons - Microtexts (1) 1
Scarborough Hospital - General (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2857) 2857
Japanese (120) 120
German (18) 18
French (17) 17
Spanish (5) 5
Arabic (3) 3
Hungarian (3) 3
Polish (3) 3
Chinese (1) 1
Russian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
LONG TERM ORAL ETOPOSIDE AS SECOND-LINE THERAPY IN RECURRENT EPITHELIAL CARCINOMA OF THE OVARY, 12/2005
Background: The activity and toxicity of etoposide in women with recurrent ovarian cancer was evaluated in a case series of women with recurrent ovarian cancer... 
Oral etoposide, recurrent epithelial ovarian cancer, second-line chemotherapy
Journal
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 1/2014, Volume 73, Issue 1, pp. 171 - 180
Journal Article
British Journal of Cancer, ISSN 0007-0920, 12/2009, Volume 101, Issue 12, pp. 1986 - 1994
Journal Article
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 02/2015, Volume 479, Issue 1, pp. 138 - 149
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2012, Volume 7, Issue 9, pp. e45268 - e45268
Journal Article
Child's Nervous System, ISSN 0256-7040, 5/2019, Volume 35, Issue 5, pp. 865 - 869
Medulloblastoma is the most common malignant brain tumor in children. Approximately 30% of children with medulloblastoma will progress or relapse despite being... 
Neurosciences | Chemotherapy | Medicine & Public Health | Relapsed medulloblastoma | Neurosurgery | Oral etoposide | Children | SURGERY | MOLECULAR SUBGROUPS | RECURRENT MEDULLOBLASTOMA | PHASE-II | CHILDHOOD | TUMORS | CLINICAL NEUROLOGY | TEMOZOLOMIDE | ADOLESCENTS | PEDIATRICS | SECONDARY LEUKEMIA | Medulloblastoma | Immunotherapy | Brain tumors | Etoposide | Metastasis | Cancer
Journal Article
The Lancet Oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1239 - 1246
Journal Article